A recent MedCity News article discussing the competitive clinical decision support market positions Atropos Health as a key player with a differentiated approach. Amid a landscape of companies focusing on synthesis of existing literature, Atropos Health is unique in its capability to generate novel real-world evidence directly at the bedside. By enabling clinicians and researchers to make data-driven decisions from their own institutional data, as well as national data sources, Atropos Health answers critical questions not answered by published literature, and provides personalized, on-demand insights that directly impact patient care.
Inside the Clinical Decision Support Market: The Race to Make AI Work at the Point of Care
